The FDA is poised to approve the notorious party drug as a therapy. Here’s what it means, and where similar drugs stand in the US. MIT Technology Review’s What’s Next series looks across ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...
It indicates an expandable section or menu, or sometimes previous / next navigation options. Paid non-client promotion: Affiliate links for the products on this page are from partners that ...
Biotech companies presented at this year's Annual Meeting of the American Society of Clinical Oncology. Find out the latest ...
AI tools have impressive potential in personalizing treatments, but doctors are concerned about bias, generalizability, and ...
A Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer's drug donanemab, which studies showed slowed early stages of the fatal mind-robbing disease. The ...
LLY has been on a tear, with their stock price hitting all-time highs recently and closing the week at around $820. However, ...
Checking our bodies for unusual lumps and bumps has become a normal way of looking after our health. But what about considering how our genes might predispose us to cancer or cognitive decline?
Affiliate links for the products on this page are from partners that compensate us and terms apply to offers listed (see our advertiser disclosure with our list of partners for more details).
June 10 (Reuters) - Outside advisers to the U.S. Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly's (LLY.N) , opens new tab experimental Alzheimer's ...